Horn & Co. is the leading Israeli boutique law firm in the field of hi-tech and life sciences and is unique in its exclusive practice and expertise in this field. The firm’s founder, Yuval Horn, was recognized by the International Who’s Who of Life Sciences Lawyers as a Global Elite Thought Leader (2018-2023) and as one of the five leading individuals in the world in life sciences transactions (2013, 2015). In 2021 Yuval received from WWL the Outstanding Lawyer Award for Life Sciences Transactions.
Horn & Co. has a unique expertise in representation of deep-tech companies that rely on research and development, focusing especially on their technology and intellectual property transactions, relations with academic or medical institutions, inventors and founders, as well as commercialization of their products and fundraising through investors, IPOs and grant programs.
Horn & Co. was founded in September 2009 and currently employs 16 lawyers and 2 articled clerks. The firm is known for its tailored, innovative structures, solutions and advice in complex transactions and situations. Since 1993, both Yuval and his colleagues have represented numerous founders, companies and investors in their transactions in the life science and technology sectors.
Tier 1 firm in Intellectual Property Transactions by D&B (2019-2023)
Tier 1 firm in High tech by D&B (2019-2023)
Tier 1 in IP Transactions by International Asset Magazine (2024)
Tier 1 firm in Hi-tech and Intellectual Property by D&B (2024)
Horn & Co. is the Israeli member of Biolegis, a network of leading European law firms with specific expertise in the representation of biotechnology and medical device companies. The firm’s partners and associates have been recognized by the leading international publications and peers as experts in corporate law, intellectual property and technology transactions and are typically asked to lecture and write about these areas. Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences noting that: “the firm has been active at the ‘top level’ in the healthcare sector for over 20 years”.
Since 2008 Yuval has been a member and legal advisor of the Institutional Review Board (Helsinki Committee) of the Chaim Sheba Medical Center at Tel-Hashomer. Yuval served as the Co-Chair of the International Bar Association (IBA) Technology Law Committee (2016-2017), is a member of the Executive Committee of the IBA Annual World Life Sciences Conference and a co-Chairman of the IBA Annual M&A in the Technology Sector Conference.